Cargando…
Deletion of PTPN22 improves effector and memory CD8(+) T cell responses to tumors
Adoptive T cell therapy (ACT) has been established as an efficacious methodology for the treatment of cancer. Identifying targets to enhance the antigen recognition, functional capacity, and longevity of T cells has the potential to broaden the applicability of these approaches in the clinic. We pre...
Autores principales: | Brownlie, Rebecca J., Wright, David, Zamoyska, Rose, Salmond, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777814/ https://www.ncbi.nlm.nih.gov/pubmed/31335326 http://dx.doi.org/10.1172/jci.insight.127847 |
Ejemplares similares
-
Resistance to TGFβ suppression and improved anti-tumor responses in CD8(+) T cells lacking PTPN22
por: Brownlie, Rebecca J., et al.
Publicado: (2017) -
Multifunctional roles of the autoimmune disease-associated tyrosine phosphatase PTPN22 in regulating T cell homeostasis
por: Salmond, Robert J, et al.
Publicado: (2015) -
The tyrosine phosphatase Ptpn22 discriminates weak, self-peptide from strong agonist T cell receptor signals
por: Salmond, Robert J., et al.
Publicado: (2014) -
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
por: Sood, Shatakshi, et al.
Publicado: (2016) -
Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2
por: Bray, Cara, et al.
Publicado: (2018)